Endocrine Board Review with Dr. Sathya Krishnasamy

[@biocarebio9619]

Thanks for making these outstanding informative teaching lectures available to the world....true spirit of medicine...alkhalifa

[@karemjbara2720]

I am 4th year resident from Jordan thanx for these amazing lectuers

[@alybec1]

I think there is a mistake in the minute 33:20 when novorapid is mentioned as the brand name of fiasp which is obviously not the case as fiasp is itself a brand name for faster acting insulin aspart while novorapid is the traditional insulin aspart.

[@Beenou87]

Thank you

[@abudaniyal715]

Thanks

[@MAAMEEMAAA]

ty so much